{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:51:56Z","timestamp":1775598716619,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Differentiating infection and sterile inflammation is the main clinical concern of clinicians as they are closely related to each other. Although <jats:sup>18<\/jats:sup>F-FDG PET\/CT imaging is widely used, its main disadvantage is its lack of specificity to discriminate aseptic from septic inflammation. <jats:sup>18<\/jats:sup>F-WBC PET\/CT scan is a promising tool for the accurate diagnosis of infection owing to its high specificity. The aim of the present study is to determine the utility of <jats:sup>18<\/jats:sup>F-WBC PET\/CT in the diagnosis of occult infections and to assess its incremental value over routine <jats:sup>18<\/jats:sup>F-FDG PET\/CT scan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>This prospective observational diagnostic accuracy study included 33 patients with fever of unknown origin or suspected periprosthetic infection and raised C-reactive protein and total leukocyte count. All the patients underwent both <jats:sup>18<\/jats:sup>F-WBC PET\/CT scan and <jats:sup>18<\/jats:sup>F-FDG PET\/CT scan using a standard protocol on 2 different days. Images of both the scans were evaluated by both visual analyses based on uptake intensity and quantitative grading based on lesion-to-background SUV<jats:sub>max<\/jats:sub> values. For interpretation of FDG PET\/CT images, visual scoring of grade 0 (undetectable or no uptake), grade 1a (less than liver uptake), grade 1b (equivalent to liver uptake), grade 2 (higher than liver uptake), and grade 3 (higher than cerebellum uptake) was used. <jats:sup>18<\/jats:sup>F-WBC PET\/CT images were also interpreted visually as grade 0 (undetectable or no uptake), grade 1a (significantly less than lumbar vertebrae or liver uptake for truncal lesions, and in case of extremity lesion slightly higher than neighboring soft tissue uptake or less than neighboring bone marrow uptake), grade 1b (equivalent to liver or lumbar vertebrae uptake for truncal lesions, and in case of extremity lesion significantly higher than neighboring soft tissue uptake or higher than neighboring bone marrow uptake), grade 2 (higher than liver or bone marrow uptake), and grade 3 (higher than twice the liver or bone marrow uptake). Similarly, a quantitative grading was also done based on lesion-to-background SUV<jats:sub>max<\/jats:sub> using a circular region of interest manually drawn. For both <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>18<\/jats:sup>F-WBC PET\/CT, the lesion-to-background ratio of &lt;1.5 was recorded as grade 0, 1.5\u20132.5 as grade 1a, 2.5\u20133.5 as grade 1b, 3.5\u20134.5 as grade 2, and &gt;4.5 as grade 3. Final diagnosis was made by histopathological, microbiological analysis, or clinical-radiological workup.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-nine foci of suspected infection were found in 25\/33 patients by either <jats:sup>18<\/jats:sup>F-FDG PET\/CT or <jats:sup>18<\/jats:sup>F-WBC PET\/CT scan. No abnormal uptake of either <jats:sup>18<\/jats:sup>F-FDG or <jats:sup>18<\/jats:sup>F-FDG WBC scan was seen in 8 patients. There was a concordance of <jats:sup>18<\/jats:sup>F-FDG PET\/CT and <jats:sup>18<\/jats:sup>F-WBC PET\/CT in 28 sites each using grade 1b of visual and quantitative analysis, respectively. Of the 29 suspicious infected foci, 18 were proven positive for infection (14\/18 sites by the histopathological\/microbiological culture and the rest 4\/18 sites by clinical\/radiological workup). Culture of aspirates or biopsy from 11\/29 suspicious sites was proven noninfective. Seven of 11 suspicious sites were proven noninfective by clinical\/radiological workup. The mean clinical follow-up was 8 months (1\u201315 months).<\/jats:p>\n            <jats:p>Overall significantly higher diagnostic accuracy was demonstrated with <jats:sup>18<\/jats:sup>F-WBC PET\/CT in comparison to <jats:sup>18<\/jats:sup>F-FDG PET\/CT for the detection of infection (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). The highest diagnostic accuracy of <jats:sup>18<\/jats:sup>F-WBC PET\/CT scan was reported with both grade 1b of visual as well as of quantitative analysis (lesion-to-background SUV<jats:sub>max<\/jats:sub>, 2.5\u20133.5) and grade 2 for both visual and quantitative analysis for <jats:sup>18<\/jats:sup>F FDG PET\/CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-WBC PET\/CT has a higher diagnostic accuracy over <jats:sup>18<\/jats:sup>F-FDG PET\/CT for the diagnosis of occult infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004317","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T18:04:19Z","timestamp":1656698659000},"page":"e574-e581","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Incremental Value of 18F-FDG\u2013Labeled Leukocytes PET\/CT Over 18F-FDG PET\/CT Scan in the Detection of Occult Infection"],"prefix":"10.1097","volume":"47","author":[{"given":"Divya","family":"Manda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subha Shankar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virupakshappa","family":"CB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmender","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"bib1-20250621","first-page":"89","article-title":"Imaging with FDG labeled leukocytes: is it clinically useful?","volume":"53","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib2-20250621","first-page":"262","article-title":"Comparison of FDG and FDG-labeled leukocytes PET\/CT in diagnosis of infection","volume":"4","year":"2015","journal-title":"Nuklearmedizin"},{"key":"bib3-20250621","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","year":"1992","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0001-2998(96)80006-7","article-title":"Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation","volume":"26","year":"1996","journal-title":"Semin Nucl Med"},{"key":"bib5-20250621","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"36","year":"1995","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00006231-200110000-00011","article-title":"Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?","volume":"22","year":"2001","journal-title":"Nucl Med Commun"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.00025-07","article-title":"Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography","volume":"21","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/RLU.0b013e3181becfb1","article-title":"F-18 FDG PET\/CT in the diagnosis of fever of unknown origin","volume":"34","year":"2009","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.114.137232","article-title":"PET\/CT with 18F-FDG-labeled autologous leukocytes for the diagnosis of infected fluid collections in acute pancreatitis","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00259-003-1425-5","article-title":"Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy","volume":"31","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0883-2897(92)90006-K","article-title":"The use of 2-[18F] fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography","volume":"19","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1148\/radiol.2382041993","article-title":"PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection","volume":"238","year":"2006","journal-title":"Radiology"},{"key":"bib13-20250621","first-page":"10.5772\/33338","article-title":"Role of nuclear medicine in infection imaging","volume":"42","year":"2012","journal-title":"Semin Roentgenol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:09Z","timestamp":1750536249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004317","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,6]]}}}